Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
US Department of Justice
Argus Health

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: RE32393

« Back to Dashboard

Summary for Patent: RE32393

Title: Composition for enhancing the administration of pharmacologically active agents
Abstract:According to the invention, the parenteral administration of water-insoluble pharmacologically active agents is enhanced wherein the agents are administered in the lipoid phase of a carrier emulsion comprising a microemulsion of a finely dispersed lipoid in an aqueous phase. The lipoid preferably has a mean particle size below 1 micron. This makes it possible to administer water-insoluble agents in high concentrations, and thus a lower dose, whereby a rapid onset of the pharmacological effect is accompanied by a markedly reduced incidence of injury to body tissues.
Inventor(s): Wretlind; Karl A. J. (Stockholm, SE), Ljungberg; Stellan (Lidingo, SE), Hakansson; Ivan (Stockholm, SE), Ajaxon; Bengt M. (Upsala, SE)
Assignee: KabiVitrum AB (Stockholm, SE)
Application Number:06/605,760
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: RE32393

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden12159/67Sep 1, 1967

International Patent Family for Patent: RE32393

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany1792410► Subscribe
Denmark129272► Subscribe
France1593013► Subscribe
France8152► Subscribe
United Kingdom1229967► Subscribe
Netherlands6812429► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Harvard Business School
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus